NEW YORK , Aug. 27, 2024 /PRNewswire/ -- Report on how AI is redefining market landscape- The global gene panel market size is estimated to grow by USD 5.40 billion from 2024-2028, according to Technavio.
The market is estimated to grow at a CAGR of almost 23.44% during the forecast period. Growing use of gene panels in cancer-targeted therapies is driving market growth, with a trend towards collaboration to maximize research efficiency.
However, large ngs gene panel implementation issues poses a challenge. Key market players include Agilent Technologies Inc., Azenta Inc.
, BGI Genomics Co. Ltd., CENTOGENE NV, Color Health Inc.
, Danaher Corp., Eurofins Scientific SE, F. Hoffmann La Roche Ltd.
, Fagron NV, GenXPro GmbH, Illumina Inc., Invitae Corp., MedGenome Labs Ltd.
, MGZ Medizinisch Genetisches Zentrum, Novogene Co. Ltd., OPKO Health Inc.
, Oxford Nanopore Technologies plc, QIAGEN NV, Quest Diagnostics Inc., and Thermo Fisher Scientific Inc..
Get a detailed analysis on regions, market segments, customer landscape, and companies - Click for the snapshot of this report Key Market Trends Fueling Growth The global life sciences tools and services market is experiencing pressure to lower costs, leading vendors to form strategic alliances along the value chain. In the gene panel market, this trend is evident with an increase in collaborations between vendors and academic institutions. Agilent Technologies Inc.
, a major player in gene panels, recently signed an MOU with Theragen Bio .